Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.05 USD
Change Today +0.0058 / 13.09%
Volume 77.0K
ICOTF On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter Hnik M.D., MHSc

Chief Medical Officer,iCo Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Dr. Peter Hnik, M.D., M.H.Sc., has been Chief Medical Officer of iCo Therapeutics Inc. since June 16, 2006. Dr. Hnik serves as an Ophthalmologist with a focus in glaucoma, neuro-ophthalmology, and deep industrial experience in retinal diseases such as age related macular degeneration and diabetic retinopathy. After practicing for years at the Eye Clinic of the Charles University Hospital where he performed surgery and consultation in glaucoma and neuro-ophthalmology, ...

Read Full Background

Corporate Headquarters*

760-777 Hornby Street
Vancouver, British Columbia V6Z 1S4


Phone: 604-602-9414
Fax: 604-602-9699

Board Members Memberships*

There is no Board Members Memberships data available.


Master's Degree 1999
University Of British Columbia
MD 1981
Univerzita Karlova v Praze

Other Affiliations*

Annual Compensation*

Total Annual CompensationC$192,000

Stock Options*

All Other CompensationC$3,327
Total Number of Options550,000

Total Compensation*

Total Annual Cash CompensationC$195,327
Total Short Term CompensationC$192,000
Other Long Term CompensationC$3,327
Total Calculated CompensationC$195,327
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ICOTF:US $0.05 USD +0.0058


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ICO THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at